このエントリーをはてなブックマークに追加
ID 68952
FullText URL
fulltext.pdf 3.02 MB
suppl.pdf 617 KB
Author
Murata, Hitoshi Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID publons researchmap
Ogawa, Kazuki Tama Biochemical Co., Ltd.
Yasui, Yu Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Ochi, Toshiki Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Tomonobu, Nahoko Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Yamamoto, Ken-Ichi Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kinoshita, Rie Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
Wada, Yoji Tama Biochemical Co., Ltd.
Nakamura, Hiromichi Tama Biochemical Co., Ltd.
Nishibori, Masahiro Department of Translational Research and Drug Development, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID publons researchmap
Sakaguchi, Masakiyo Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Abstract
Sterile alpha and Toll/interleukin receptor motif-containing protein 1 (SARM1) is a nicotinamide adenine dinucleotide (NAD+) hydrolase involved in axonal degeneration and neuronal cell death. SARM1 plays a pivotal role in triggering the neurodegenerative processes that underlie peripheral neuropathies, traumatic brain injury, and neurodegenerative diseases. Importantly, SARM1 knockdown or knockout prevents the degeneration; as a result, SARM1 has been attracting attention as a potent therapeutic target. In recent years, the development of several SARM1 inhibitors derived from synthetic chemical compounds has been reported; however, no dietary ingredients with SARM1 inhibitory activity have been identified. Therefore, we here focused on dietary ingredients and found that carnosol, an antioxidant contained in rosemary, inhibits the NAD+-cleavage activity of SARM1. Purified carnosol inhibited the enzymatic activity of SARM1 and suppressed neurite degeneration and cell death induced by the anti-cancer medicine vincristine (VCR). Carnosol also inhibited VCR-induced hyperalgesia symptoms, suppressed the loss of intra-epidermal nerve fibers in vivo, and reduced the blood fluid level of phosphorylated neurofilament-H caused by an axonal degeneration event. These results indicate that carnosol has a neuroprotective effect via SARM1 inhibition in addition to its previously known antioxidant effect via NF-E2-related factor 2 and thus suppresses neurotoxin-induced peripheral neuropathy.
Keywords
SARM1
carnosol
NAD+
axon degeneration
peripheral neuropathy
Published Date
2025-06-30
Publication Title
Antioxidants
Volume
volume14
Issue
issue7
Publisher
MDPI AG
Start Page
808
ISSN
2076-3921
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2025 by the authors.
File Version
publisher
DOI
Related Url
isVersionOf https://doi.org/10.3390/antiox14070808
License
https://creativecommons.org/licenses/by/4.0/
Citation
Murata, H.; Ogawa, K.; Yasui, Y.; Ochi, T.; Tomonobu, N.; Yamamoto, K.-I.; Kinoshita, R.; Wada, Y.; Nakamura, H.; Nishibori, M.; et al. Carnosol, a Rosemary Ingredient Discovered in a Screen for Inhibitors of SARM1-NAD+ Cleavage Activity, Ameliorates Symptoms of Peripheral Neuropathy. Antioxidants 2025, 14, 808. https://doi.org/10.3390/antiox14070808
助成情報
22K06884: 軸索変性誘導分子SARM1の活性・分解制御によるパーキンソン病治療法の開発 ( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
24R8: ( 公益財団法人岡山医学振興会 / Okayama Medical Foundation )